Actinium Pharmaceuticals (ATNM): Actinium could see a massive sales jump from its radiotherapy business. Outlook Therapeutics (OTLK): Outlook is poised to generate revenue for its monoclonal antibody ...
Source LinkActinium Pharmaceuticals (ATNM): Actinium could see a massive sales jump from its radiotherapy business. Outlook Therapeutics (OTLK): Outlook is poised to generate revenue for its monoclonal antibody ...
Source Link
Comments